Related Experiment Video
Updated: Aug 17, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Biochemical changes in the serum of patients with chronic toxigenic mold exposures: a risk factor for multiple renal
Ebere Anyanwu1, Andrew W Campbell, Aristo Vojdani
1Neurosciences Research, Cahers Inc., Conroe, TX, USA. ebereanyanwu@msn.com
Abstract:
This paper analyzes and presents the biochemical abnormalities in the sera of patients presenting with chronic mycosis in order to investigate the relationship with the risks of multiple renal disorders. The study population (n = 10) consisted of six females and four males (mean age 36.3 years) exposed by toxic molds in their homes and offices for an average of 2.8 years. The control group comprised ten people, five males and five females (mean age 35.9 years) without any known exposures to toxic molds. Blood samples were obtained from both the patients and the controls and were processed using specific biochemical methods that included enzyme-linked immunoabsorbent assay (ELISA). There were biochemical abnormal concentrations in creatinine, uric acid, phosphorus, alkaline phosphotase, cholesterol, HDH, SGOT/AST, segmented neutrophils, lymphocytes, total T3, IgG and IgA immunoglobulins with significant differences between patients and controls. These abnormalities were consistent with multiple renal disorders. The major complaints of the mycosis patients were headaches, pulmonary symptoms, allergic reactions, memory loss, skin rashes, blurred vision symptoms, fatigue, and runny nose. These findings were depictive of a strong association of chronic mycosis with abnormal renal indicators. It was concluded that, although this research was a pilot investigation, based on the overall results, people exposed to chronic indoor environmental toxic molds were at risk of multiple renal complications.
Insights
Chronic exposure to toxic molds is linked to biochemical abnormalities and increased risk of kidney disorders. This pilot study highlights potential renal complications in individuals with mycosis due to indoor mold exposure.
Area of Science:
- Environmental Health
- Biochemistry
- Nephrology
Background:
- Chronic mycosis, often linked to indoor environmental exposures like toxic molds, can manifest with diverse symptoms.
- Understanding the biochemical underpinnings of mycosis is crucial for identifying associated health risks, particularly renal complications.
Purpose of the Study:
- To analyze serum biochemical abnormalities in patients with chronic mycosis.
- To investigate the association between these biochemical changes and the risk of developing multiple renal disorders.
Main Methods:
- A pilot study involving 10 patients with chronic mycosis and 10 healthy controls.
- Biochemical analysis of blood samples using methods including enzyme-linked immunoabsorbent assay (ELISA).
Main Results:
- Patients exhibited abnormal concentrations of creatinine, uric acid, phosphorus, alkaline phosphatase, cholesterol, LDH, SGOT/AST, neutrophils, lymphocytes, T3, IgG, and IgA compared to controls.
- These biochemical abnormalities were consistent with multiple renal disorders.
- Common symptoms reported by patients included headaches, respiratory issues, allergies, memory loss, skin rashes, blurred vision, fatigue, and runny nose.
Conclusions:
- Chronic exposure to indoor toxic molds is associated with significant biochemical abnormalities.
- These findings suggest a strong link between chronic mycosis and indicators of renal dysfunction.
- Individuals exposed to indoor molds may be at risk for multiple renal complications, warranting further investigation.
More Related Videos
06:32Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Acute Kidney Injury III: Clinical Manifestations
Toxoplasmosis
Diabetic Nephropathy